Management options for established chemotherapy-induced peripheral neuropathy.
| Title: | Management options for established chemotherapy-induced peripheral neuropathy. |
|---|---|
| Authors: | Pachman DR; Division of Medical Oncology, Mayo Clinic, 200 First Street, SW, Rochester, MN, 55905, USA, pachman.deirdre@mayo.edu.; Watson JC; Lustberg MB; Wagner-Johnston ND; Chan A; Broadfield L; Cheung YT; Steer C; Storey DJ; Chandwani KD; Paice J; Jean-Pierre P; Oh J; Kamath J; Fallon M; Strik H; Koeppen S; Loprinzi CL |
| Source: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2014 Aug; Vol. 22 (8), pp. 2281-95. Date of Electronic Publication: 2014 May 31. |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Berlin : Springer International, c1993- |
| MeSH Terms: | Antineoplastic Agents/*adverse effects ; Neoplasms/*drug therapy ; Peripheral Nervous System Diseases/*chemically induced ; Peripheral Nervous System Diseases/*therapy; Antineoplastic Agents/therapeutic use ; Peripheral Nervous System Diseases/drug therapy ; Humans ; Treatment Outcome |
| Abstract: | Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating condition associated with a variety of chemotherapeutic agents. Clinicians are cognizant of the negative impact of CIPN on cancer treatment outcomes and patients' psychosocial functioning and quality of life. In an attempt to alleviate this problem, clinicians and patients try various therapeutic interventions, despite limited evidence to support efficacy of these treatments. The rationale for such use is mostly based on the evidence for the treatment options in non-CIPN peripheral neuropathy syndromes, as this area is more robustly studied than is CIPN treatment. In this manuscript, we examine the existing evidence for both CIPN and non-CIPN treatments and develop a summary of the best available evidence with the aim of developing a practical approach to the treatment of CIPN, based on available literature and clinical practice experience. |
| References: | JOP. 2003 Jan;4(1):1-10. (PMID: 12555009); J Neurochem. 2010 Aug;114(3):820-31. (PMID: 20477950); Clin Pharmacol Ther. 2004 Mar;75(3):234-41. (PMID: 15001975); Anticancer Res. 2010 Jul;30(7):2927-33. (PMID: 20683034); J Pain Symptom Manage. 2010 Dec;40(6):883-91. (PMID: 20813492); Support Care Cancer. 2013 Jul;21(7):2059-66. (PMID: 23446880); Tumori. 2005 Mar-Apr;91(2):135-8. (PMID: 15948540); Physiol Res. 2004;53(3):351-5. (PMID: 15209544); J Acupunct Meridian Stud. 2010 Jun;3(2):95-103. (PMID: 20633522); Cancer. 2008 Jun 15;112(12):2802-8. (PMID: 18428211); Epilepsia. 1986 Sep-Oct;27(5):490-7. (PMID: 3757936); Oncologist. 2011;16(5):708-16. (PMID: 21478275); Ann Oncol. 2003 Feb;14(2):339-40. (PMID: 12562664); BMC Neurol. 2008 Sep 16;8:33. (PMID: 18796160); Clin Pharmacokinet. 2010 Oct;49(10):661-9. (PMID: 20818832); Pain. 2007 Dec 5;132(3):237-251. (PMID: 17920770); Neurology. 2003 Mar 25;60(6):927-34. (PMID: 12654955); Diabetes Care. 1995 Aug;18(8):1160-7. (PMID: 7587852); Pain Med. 2005 Sep-Oct;6(5):346-56. (PMID: 16266355); Pain Med. 2008 Apr;9(3):354-8. (PMID: 18366513); Support Care Cancer. 2012 Oct;20(10):2621-6. (PMID: 22699304); J Pain Symptom Manage. 2007 Oct;34(4):446-54. (PMID: 17662571); Curr Med Chem. 2008;15(29):3081-94. (PMID: 19075655); Neurology. 2000 Jun 13;54(11):2115-9. (PMID: 10851374); Neurology. 2003 May 13;60(9):1508-14. (PMID: 12743240); Acupunct Med. 2006 Jun;24(2):87-91. (PMID: 16783284); Pain Med. 2000 Mar;1(1):97-100. (PMID: 15101968); Pain. 2005 Jul;116(1-2):109-18. (PMID: 15927394); Am J Med. 2009 Oct;122(10 Suppl):S22-32. (PMID: 19801049); J Pain Symptom Manage. 2012 Jan;43(1):87-95. (PMID: 21763099); Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005454. (PMID: 17943857); Clin J Pain. 2003 Sep-Oct;19(5):323-8. (PMID: 12966259); Support Care Cancer. 2012 Mar;20(3):583-9. (PMID: 21380613); J Pain. 2005 Apr;6(4):253-60. (PMID: 15820913); Expert Opin Investig Drugs. 2004 Nov;13(11):1445-56. (PMID: 15500392); J Pain Palliat Care Pharmacother. 2013 Dec;27(4):359-64. (PMID: 24143893); J Tradit Chin Med. 2006 Mar;26(1):8-12. (PMID: 16705843); Neurology. 2003 Apr 22;60(8):1284-9. (PMID: 12707430); Neurology. 2006 Oct 24;67(8):1411-20. (PMID: 17060567); Breast Cancer Res Treat. 2011 Feb;125(3):767-74. (PMID: 21128110); Qual Life Res. 2014 Jun;23(5):1629-40. (PMID: 24326731); Pain. 2004 May;109(1-2):132-42. (PMID: 15082135); Anticancer Drugs. 2002 Aug;13(7):777-80. (PMID: 12187335); Pain. 1999 Oct;83(1):105-7. (PMID: 10506679); CNS Drugs. 2007;21 Suppl 1:31-8; discussion 45-6. (PMID: 17696591); Lancet Neurol. 2008 Dec;7(12):1106-12. (PMID: 18977178); Phys Ther. 2010 Nov;90(11):1568-79. (PMID: 20798179); Pain. 2007 Mar;128(1-2):169-79. (PMID: 17161535); Chemother Res Pract. 2012;2012:913848. (PMID: 22482054); Support Care Cancer. 2012 Feb;20(2):405-12. (PMID: 21394458); Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003904. (PMID: 15495069); Clin J Pain. 2002 May-Jun;18(3):200-2. (PMID: 12048423); Eur J Pain. 2008 Feb;12(2):203-13. (PMID: 17631400); J Pain Symptom Manage. 2010 Jun;39(6):e2-4. (PMID: 20538177); Minerva Anestesiol. 2005 Jul-Aug;71(7-8):479-82. (PMID: 16012423); J Pain Symptom Manage. 2008 Jan;35(1):31-9. (PMID: 17980550); Support Care Cancer. 2014 Jul;22(7):1807-14. (PMID: 24531792); Support Care Cancer. 2014 Jan;22(1):95-101. (PMID: 23995813); Pain Med. 2008 Nov;9(8):1209-16. (PMID: 19067834); Ann Oncol. 2014 Jan;25(1):257-64. (PMID: 24256846); Pain. 2011 Aug;152(8):1705-1708. (PMID: 21396781); J Clin Oncol. 2002 Aug 1;20(15):3359-61. (PMID: 12149316); Anticancer Drugs. 2005 Jun;16(5):587-91. (PMID: 15846125); Support Care Cancer. 2012 Jul;20(7):1491-7. (PMID: 21814779); Diabetes Care. 2006 Nov;29(11):2365-70. (PMID: 17065669); J Pain. 2011 Sep;12(9):1017-24. (PMID: 21703938); Neurology. 2001 Aug 14;57(3):505-9. (PMID: 11502921); Pain. 2003 Sep;105(1-2):71-8. (PMID: 14499422); Ann Oncol. 2012 Jan;23(1):200-205. (PMID: 21427067); Neurology. 2008 Jun 10;70(24):2305-13. (PMID: 18541884); J Clin Oncol. 2013 Jul 10;31(20):2627-33. (PMID: 23733756); Cancer. 2012 Mar 15;118(6):1718-25. (PMID: 21837673); Diabetes Care. 2008 Jul;31(7):1448-54. (PMID: 18356405); Zhongguo Zhen Jiu. 2010 Jun;30(6):457-60. (PMID: 20578381); Pain. 2002 Oct;99(3):557-566. (PMID: 12406532); Cancer. 2007 Nov 1;110(9):2110-8. (PMID: 17853395); J Diabetes Complications. 2008 Jul-Aug;22(4):241-5. (PMID: 18413214); Neurology. 2001 Jan 23;56(2):184-90. (PMID: 11160953); Support Care Cancer. 2011 Jun;19(6):833-41. (PMID: 20496177); Curr Biol. 2006 Aug 22;16(16):1591-605. (PMID: 16920620); J Rehabil Med. 2010 Apr;42(4):289-95. (PMID: 20461329); Cochrane Database Syst Rev. 2012 Sep 12;(9):CD010111. (PMID: 22972149); Diabetes Care. 2005 Jan;28(1):89-94. (PMID: 15616239); Diabetes Res Clin Pract. 2010 Jul;89(1):10-5. (PMID: 20510476); Neurology. 2011 May 17;76(20):1758-65. (PMID: 21482920); Diabet Med. 2004 Feb;21(2):114-21. (PMID: 14984445); Acupunct Med. 2012 Mar;30(1):4-7. (PMID: 22146780); Pain. 2002 Jul;98(1-2):195-203. (PMID: 12098632); CNS Drugs. 2007;21 Suppl 1:13-23; discussion 45-6. (PMID: 17696589); Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006044. (PMID: 21328280); Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007393. (PMID: 23450576); N Engl J Med. 2003 Mar 27;348(13):1223-32. (PMID: 12660386); Acupunct Med. 2011 Sep;29(3):230-3. (PMID: 21875929); J Clin Oncol. 2008 Sep 20;26(27):4519-20. (PMID: 18802169); Eur J Cancer. 2005 Aug;41(12):1746-50. (PMID: 16039110); Pain. 2004 Aug;110(3):697-706. (PMID: 15288411); J Pain. 2005 Oct;6(10):644-9. (PMID: 16202956); JAMA. 1998 Dec 2;280(21):1831-6. (PMID: 9846777); Support Care Cancer. 2012 Mar;20(3):625-32. (PMID: 21479990); Support Care Cancer. 2014 May;22(5):1223-31. (PMID: 24362907); JAMA. 2013 Apr 3;309(13):1359-67. (PMID: 23549581); Anesthesiology. 2005 Jul;103(1):140-6. (PMID: 15983466); Ann Pharmacother. 2008 Nov;42(11):1686-91. (PMID: 18940920); Pain. 2002 Apr;96(3):375-383. (PMID: 11973012); CNS Drugs. 2007;21 Suppl 1:39-43; discussion 45-6. (PMID: 17696592); Neurology. 2002 Oct 8;59(7):1015-21. (PMID: 12370455); Mayo Clin Proc. 2010 Mar;85(3 Suppl):S3-14. (PMID: 20194146); Diabetes Res Clin Pract. 1998 Feb;39(2):115-21. (PMID: 9597381); Anticancer Drugs. 2003 Jul;14(6):423-5. (PMID: 12853883) |
| Substance Nomenclature: | 0 (Antineoplastic Agents) |
| Entry Date(s): | Date Created: 20140601 Date Completed: 20140901 Latest Revision: 20220801 |
| Update Code: | 20260130 |
| DOI: | 10.1007/s00520-014-2289-x |
| PMID: | 24879391 |
| Database: | MEDLINE |
Journal Article; Review